X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3098) 3098
Publication (143) 143
Book Review (30) 30
Book / eBook (19) 19
Magazine Article (7) 7
Conference Proceeding (4) 4
Book Chapter (3) 3
Dissertation (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1893) 1893
hemostatics - pharmacology (1378) 1378
animals (1303) 1303
male (931) 931
index medicus (914) 914
hemostatics (738) 738
female (700) 700
rats (443) 443
pharmacology & pharmacy (437) 437
hematology (420) 420
thrombin - pharmacology (419) 419
hemostasis (412) 412
adult (379) 379
thrombin (371) 371
hemostatics - therapeutic use (370) 370
blood coagulation - drug effects (368) 368
middle aged (360) 360
surgery (335) 335
peripheral vascular disease (289) 289
mice (252) 252
blood (241) 241
aged (239) 239
coagulation (233) 233
hemostatics - administration & dosage (222) 222
rabbits (217) 217
fibrinogen (209) 209
hemostasis - drug effects (208) 208
time factors (203) 203
blood coagulation (200) 200
cells, cultured (198) 198
thrombosis (198) 198
hemorrhage (186) 186
dose-response relationship, drug (175) 175
proteins (171) 171
blood platelets - drug effects (170) 170
disease models, animal (166) 166
analysis (165) 165
fibrin (158) 158
platelets (156) 156
pharmacology (154) 154
prothrombin (152) 152
anticoagulants - pharmacology (148) 148
coagulants (144) 144
research (143) 143
rats, sprague-dawley (142) 142
blood platelets (140) 140
activation (138) 138
platelet aggregation - drug effects (138) 138
treatment outcome (138) 138
medicine (136) 136
rats, wistar (131) 131
fibrinolysis (130) 130
cardiac & cardiovascular systems (129) 129
blood platelets - metabolism (128) 128
blood coagulation tests (126) 126
aprotinin - pharmacology (125) 125
hemostatics - chemistry (124) 124
biochemistry & molecular biology (123) 123
anticoagulants (119) 119
toxicology (116) 116
drugs (115) 115
in vitro techniques (115) 115
hemostatics - adverse effects (113) 113
plasma (113) 113
cardiopulmonary bypass (111) 111
in-vitro (110) 110
medicine, research & experimental (110) 110
physiology (108) 108
bleeding (107) 107
dogs (107) 107
research article (107) 107
blood loss, surgical - prevention & control (105) 105
enzymes (105) 105
swine (105) 105
risk factors (104) 104
cell biology (103) 103
prospective studies (103) 103
wound healing - drug effects (101) 101
hemorrhage - drug therapy (99) 99
collagen (95) 95
health aspects (95) 95
hemostatic techniques (95) 95
cells (94) 94
kinetics (93) 93
adolescent (92) 92
expression (91) 91
anesthesiology (90) 90
prothrombin time (89) 89
thrombin - metabolism (88) 88
multidisciplinary sciences (87) 87
chitosan (86) 86
cattle (85) 85
tissue factor (85) 85
inflammation (84) 84
model (84) 84
collagen - pharmacology (82) 82
inhibition (82) 82
heparin - pharmacology (81) 81
vitamin k - pharmacology (81) 81
fibrinogen - metabolism (80) 80
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2772) 2772
German (76) 76
Russian (58) 58
Chinese (57) 57
French (48) 48
Japanese (31) 31
Italian (30) 30
Spanish (11) 11
Polish (9) 9
Czech (7) 7
Dutch (7) 7
Ukrainian (6) 6
Hungarian (5) 5
Swedish (5) 5
Serbian (4) 4
Bulgarian (1) 1
Hebrew (1) 1
Portuguese (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Biological Chemistry, ISSN 0021-9258, 04/2001, Volume 276, Issue 17, pp. 13750 - 13755
Journal Article
1954, American lecture series, publication no. 217, 71
Book
European Heart Journal, ISSN 0195-668X, 02/2013, Volume 34, Issue 7, pp. 489 - 500
Novel oral anticoagulants that directly inhibit thrombin (dabigatran) or factor Xa (rivaroxaban, apixaban) are currently available for prevention of venous... 
Novel oral anticoagulants | Bleeding | Management | RECOMBINANT FACTOR-VIIA | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | RANDOMIZED EVALUATION | INTRACRANIAL HEMORRHAGE | ACTIVATED FACTOR-VII | FACTOR-XA INHIBITOR | DABIGATRAN ETEXILATE | VENOUS THROMBOEMBOLISM | PROTHROMBIN COMPLEX CONCENTRATE | NONVALVULAR ATRIAL-FIBRILLATION | Plasma | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Antithrombins - administration & dosage | Hemorrhage - prevention & control | Thiophenes - administration & dosage | Dabigatran | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | beta-Alanine - pharmacology | Renal Insufficiency - complications | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Morpholines - adverse effects | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Acute Disease | beta-Alanine - adverse effects | Administration, Oral | Morpholines - administration & dosage | Risk Factors | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Anticoagulants - adverse effects | Pyrazoles - administration & dosage | Anticoagulants - pharmacology | Antithrombins - adverse effects | Blood Coagulation Tests | Benzimidazoles - pharmacology | Aged | Hemostatics - therapeutic use | Pyridones - adverse effects | Pyridones - pharmacology | Renal Dialysis
Journal Article
Journal Article
Acta Pharmacologica Sinica, ISSN 1671-4083, 12/2008, Volume 29, Issue 12, pp. 1419 - 1424
Aim: Endothelium-dependent relaxations to certain neurohumoral substances are mediated by pertussis toxin-sensitive Gi/o protein. Our experiments were designed... 
CELLS | DEPENDENT RELAXATION | ANANDAMIDE | MESENTERIC-ARTERY | NATRIURETIC PEPTIDE | CHEMISTRY, MULTIDISCIPLINARY | endothelium-derived hyperpolarizing factor | Gi/o protein | pig coronary artery | L-ARGININE | pertussis toxin | PHARMACOLOGY & PHARMACY | RECEPTORS | EXPRESSION | EDHF | Endothelium-Dependent Relaxing Factors - pharmacology | Hemostatics - pharmacology | Peptide Fragments - pharmacology | Substance P - pharmacology | Apamin - pharmacology | Serotonin - pharmacology | Dose-Response Relationship, Drug | Thrombin - pharmacology | Charybdotoxin - pharmacology | Neurotransmitter Agents - pharmacology | Dinoprost - pharmacology | Bradykinin - pharmacology | Ionophores - pharmacology | Pertussis Toxin - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Ketanserin - pharmacology | Coronary Vessels - drug effects | Vasodilator Agents - pharmacology | Coronary Vessels - physiology | Enzyme Inhibitors - pharmacology | Serotonin Antagonists - pharmacology | Calcimycin - pharmacology | Neurotoxins - pharmacology | Animals | Muscle Relaxation - drug effects | GTP-Binding Protein alpha Subunits, Gi-Go - metabolism | Sus scrofa | Biological Factors - pharmacology | Tocolytic agents | Swine | Tachykinins | Bradykinin | Thrombin | Indomethacin | Carbonates | Endothelium-derived relaxing factors | Peptide hormones | Arteries | Endothelium | Index Medicus
Journal Article
Journal Article
Carbohydrate Polymers, ISSN 0144-8617, 02/2018, Volume 181, pp. 668 - 674
In this work, an gelling system composed of glycol chitosan (GC) was fabricated and evaluated regarding its tissue-adhesive, anti-bacterial and hemostatic... 
Glycol chitosan | Photochemical crosslinking | Hydrogel | Tissue adhesive | Antibacterial | Hemostasis | SEALANTS | POLYMER SCIENCE | SURGICAL APPLICATIONS | DRUG-DELIVERY | CHEMISTRY, ORGANIC | INJECTABLE CHITOSAN | HEMOSTATIC MATERIALS | IN-VITRO | BIOMEDICAL APPLICATIONS | DRESSINGS | BIOMATERIALS | CHEMISTRY, APPLIED | FIBRINOGEN | Cross-Linking Reagents - radiation effects | Staphylococcus epidermidis - drug effects | Escherichia coli - drug effects | Phenylpropionates - chemistry | Tissue Adhesives - pharmacology | Drug Carriers - toxicity | Hemostatics - pharmacology | Elastic Modulus | Hydrogels - chemical synthesis | Drug Carriers - chemistry | Gentamicins - pharmacology | Swine | Light | Phenylpropionates - toxicity | Tissue Adhesives - chemical synthesis | Chitosan - pharmacology | Hydrogels - toxicity | Chitosan - radiation effects | Phenylpropionates - radiation effects | Chitosan - chemical synthesis | Cell Line | Hemostatics - chemistry | Hemostatics - toxicity | Cross-Linking Reagents - chemistry | Cross-Linking Reagents - toxicity | Drug Carriers - chemical synthesis | Chitosan - toxicity | Organometallic Compounds - radiation effects | Drug Carriers - pharmacology | Animals | Amoxicillin - pharmacology | Chickens | Tissue Adhesives - toxicity | Drug Liberation | Anti-Bacterial Agents - pharmacology | Mice | Hemostatics - chemical synthesis | Hydrogels - pharmacology | Tissue Adhesives - chemistry | Hydrogels - chemistry | Crosslinked polymers | Glycols | Adhesives | Antibacterial agents | Analysis | Liver
Journal Article
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2008, Volume 283, Issue 27, pp. 18493 - 18504
Human platelets express protease-activated receptor 1 (PAR1) and PAR4 but limited data indicate for differences in signal transduction. We studied the... 
Receptor, PAR-1 - metabolism | Humans | Thrombin - antagonists & inhibitors | Receptors, Adrenergic, alpha-2 - metabolism | Secretory Vesicles - metabolism | Hemostatics - pharmacology | Peptide Fragments - pharmacology | Epinephrine - antagonists & inhibitors | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Epinephrine - agonists | Dose-Response Relationship, Drug | Adrenergic alpha-2 Receptor Agonists | Receptors, Thrombin - agonists | Thrombin - pharmacology | Blood Platelets - cytology | Adenosine Triphosphate - metabolism | Thrombin - agonists | Platelet Aggregation Inhibitors - pharmacology | Platelet Aggregation - drug effects | Aspirin - pharmacology | Aspirin - agonists | Chromones - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Aspirin - antagonists & inhibitors | Oligopeptides - antagonists & inhibitors | Calcium - pharmacology | Receptor, PAR-1 - agonists | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Platelet Aggregation - physiology | Purinergic P2 Receptor Agonists | Oligopeptides - agonists | Receptors, Purinergic - metabolism | Receptors, Purinergic P2X | Drug Synergism | Drug Antagonism | Purinergic Agonists | Blood Platelets - metabolism | Peptide Fragments - agonists | Peptide Fragments - antagonists & inhibitors | Receptors, Purinergic P2 - metabolism | Receptors, Thrombin - metabolism | Adrenergic alpha-Agonists - pharmacology | Adenosine Diphosphate - metabolism | Adrenergic alpha-2 Receptor Antagonists | Oligopeptides - pharmacology | Epinephrine - pharmacology | Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Journal of Ethnopharmacology, ISSN 0378-8741, 01/2017, Volume 195, pp. 20 - 38
Journal Article